Navigation Links
Neptune Reports Year End Financial Results - Neptune Records 18% Sales Increase and 43% EBITDA Increase in Year End Results
Date:9/28/2007

LAVAL, QC, Sept. 28 /PRNewswire-FirstCall/ - Neptune Technologies & Bioressources Inc. (NASDAQ.NEPT - TSX.V.NTB), is pleased to report its financial results for the fiscal year ended May 31, 2007. During the last fiscal year, Neptune improved its productivity and operational profitability while continuing its business development strategy to penetrate the American, European and Asian markets, resulting in sustainable sales growth.

Financial Results and Highlights:

- Sales increased by 18% to $8,126,000 from $6,912,000 in the preceding

fiscal year.

- EBITDA increased by 43% to $1,504,000 from $1,049,000 in the preceding

fiscal year, representing a third consecutive year with a positive

EBITDA.

- EBITDA margin reached 18.5%, compared to 15.2% in the preceding fiscal

year.

- Excluding stock-based compensation expenses, Neptune would have

realized earnings of $152,000 instead of a loss of $2,677,000 in the

fiscal year ended May 31, 2007. Excluding stock-based compensation

expenses and an extraordinary gain from the settlement of debentures,

Neptune would have realized a loss of $1,574,000 instead of a loss of

$886,000 in the fiscal year ended May 31, 2006.

"We believe that the evaluation model and accounting method for stock-based compensation expenses are not appropriate for small capitalization fast growing companies. They do not bring the accounting value of stock-based compensation closer to the market value, as they should and as they were implemented for", stated Xavier Harland, Director of Finance.

"Neptune has managed to increase its EBITDA by $455,000 with a $1.2M increase in sales, confirming its improvement in operational efficiency", stated Andre Godin, Vice-President, Administration and Finance.

Neptune continues to strongly support its strategic development plan to pursue partnerships/strategic alliances with worldwide leaders in
'/>"/>

SOURCE NEPTUNE TECHNOLOGIES & BIORESSOURCES INC.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... Massachusetts , June 1, 2015 ... announces that it will be participating in the Jefferies ... NY on Tuesday, June 2, 2015. ... a question and answer session at 10:00 a.m. ET ... will be available on the Presentations and Webcasts section ...
(Date:6/1/2015)... May 29, 2015 Research and Markets ... the "2015 Strategies in the UK Flow ... This report presents a comprehensive analysis of ... Major issues pertaining to the French flow cytometry ... social and technological trends with significant market impact ...
(Date:6/1/2015)... June 1, 2015 Hutchison ... that AstraZeneca AB (publ) ("AstraZeneca"), Hutchison MediPharma Limited,s ... ongoing Phase Ib clinical trial of HMP,s c-Met ... AZD9291 in non-small cell lung cancer ("NSCLC"). ... epidermal growth factor receptor (EGFR). Preliminary data on ...
(Date:5/31/2015)... (PRWEB) May 31, 2015 The most ... Society of Clinical Oncology (ASCO) Annual Meeting – “The ... Lecture” – prominently featured presentations by immunotherapy experts and ... , James Patrick Allison, PhD, chairman of the Department ... Cancer Center and SITC committee member, received the Science ...
Breaking Biology Technology:Strategies in the UK Flow Cytometry Market 2015 2Savolitinib (AZD6094) Preliminary Phase Ib Clinical Data in Lung Cancer Presented at the 2015 ASCO Annual Meeting 2Savolitinib (AZD6094) Preliminary Phase Ib Clinical Data in Lung Cancer Presented at the 2015 ASCO Annual Meeting 3SITC Reports on Immunotherapy Insights and Data Featured at ASCO Plenary Session 2
... April 28 PharmAthene, Inc. (NYSE Amex: PIP ... threats, today announced the appointment of Mitchel Sayare , Ph.D. ... members. , , ... Dr. Sayare most recently served as Chairman and Chief Executive Officer ...
... ... and Recognition of Science and Technology), a not-for-profit organization founded by inventor Dean Kamen ... Supplier of the FIRST Robotics Competition (FRC®). , ... (PRWEB) April 28, 2010 -- Haydon Kerk Motion Solutions, ...
... Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) will be presenting at ... Tuesday, May 4, 2010 at 10:40 a.m. ET / ... chief executive officer of Amylin Pharmaceuticals, will provide a corporate overview. , ... The presentation will be webcast live through the ...
Cached Biology Technology:PharmAthene Appoints Mitchel Sayare, Ph.D. to the Company's Board of Directors 2PharmAthene Appoints Mitchel Sayare, Ph.D. to the Company's Board of Directors 3Haydon Kerk Motion Solutions Inspires Next Generation of Innovators as Silver Supplier of the FIRST Robotics Competition 2Haydon Kerk Motion Solutions Inspires Next Generation of Innovators as Silver Supplier of the FIRST Robotics Competition 3Haydon Kerk Motion Solutions Inspires Next Generation of Innovators as Silver Supplier of the FIRST Robotics Competition 4Amylin Pharmaceuticals to Present at the Deutsche Bank 35th Annual Healthcare Conference 2
(Date:4/27/2015)... Apr. 27, 2015 Profile Solutions, Inc. (OTC: ... security systems is pleased to announce that Dr ... consultant and member of its scientific advisory board. ... as a thought leader in technology-enhanced learning models. He ... and has published studies and books focused on online ...
(Date:4/20/2015)... 20, 2015 Huntington Memorial Hospital is the ... a new miniaturized, wireless monitoring sensor to manage heart ... and only FDA-approved heart failure monitoring device that has ... by physicians to manage heart failure. The ... in the pulmonary artery (PA) during a non-surgical procedure ...
(Date:4/17/2015)... 17, 2015 Increasing ... technological advancement to drive biometric systems market in ...   According to a recently released ... &  Opportunities, 2020 ", biometric systems market in ... growth at CAGR of over 22% through 2020. ...
Breaking Biology News(10 mins):Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3
... an ongoing effort to mirror the ability of biological ... scientists from the McGowan Institute for Regenerative Medicine have ... both biological and chemical toxins. They described the findings ... biological principles to create materials that can do many ...
... University of Florida engineering researchers have found they can ... say opens the door to a wave of new technologies ... about the research appears in this week,s advance online edition ... Ben Koopman and Brij Moudgil say they used lasers not ...
... from the Robertson Foundation to create a state-of-the-art Translational ... cell therapy research and treatment programs for children and ... suffered at birth. In making the announcement, Victor J. ... Chief Executive Officer for Duke University Health System, said ...
Cached Biology News:Multifunctional polymer neutralizes both biological and chemical weapons 2Engineers: Weak laser can ignite nanoparticles, with exciting possibilities 2Engineers: Weak laser can ignite nanoparticles, with exciting possibilities 3Robertson Foundation donates $10.2 million for Duke Cell Therapy Center 2Robertson Foundation donates $10.2 million for Duke Cell Therapy Center 3